Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition

Eleftherios Pierre Samartzis(University Hospital of Zurich), Patrick Imesch(University Hospital of Zurich)
Oncotarget
June 11, 2014
Cited by 145


Related Papers